SIRT1 and metabolic dysfunction-associated steatotic liver disease: DG, a natural SIRT1 activator, alleviates NAFLD through the SIRT1/PGC-1α pathway and mitigates fatty acid uptake by regulating SIRT6-mediated mechanisms [82,83].